Adaptive Biotechnologies Corporation
ADPT
$24.66
$0.321.32%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 50.13% | 55.87% | 54.77% | 42.57% | 21.60% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 50.13% | 55.87% | 54.77% | 42.57% | 21.60% |
| Cost of Revenue | -1.16% | -0.98% | -5.66% | -8.66% | -12.59% |
| Gross Profit | 263.05% | 497.60% | 2,750.36% | 1,871.45% | 294.87% |
| SG&A Expenses | 13.27% | 11.57% | 6.16% | 1.43% | -2.50% |
| Depreciation & Amortization | 0.06% | 0.00% | -0.23% | -0.35% | -0.35% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.89% | 5.04% | -0.06% | -3.92% | -7.88% |
| Operating Income | 69.07% | 65.69% | 63.23% | 53.22% | 34.70% |
| Income Before Tax | 47.22% | 65.01% | 62.75% | 59.25% | 43.23% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 47.22% | 65.01% | 62.75% | 59.25% | 43.23% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1,600.00% | -169.09% | -140.78% | -116.35% | -92.31% |
| Net Income | 47.33% | 64.97% | 62.69% | 59.22% | 43.21% |
| EBIT | 69.07% | 65.69% | 63.23% | 53.22% | 34.70% |
| EBITDA | 79.26% | 74.63% | 71.13% | 59.10% | 37.33% |
| EPS Basic | 50.39% | 66.29% | 63.63% | 60.03% | 44.49% |
| Normalized Basic EPS | 68.97% | 64.78% | 62.11% | 52.13% | 35.14% |
| EPS Diluted | 49.80% | 65.75% | 63.16% | 59.92% | 44.31% |
| Normalized Diluted EPS | 68.49% | 64.35% | 61.73% | 51.78% | 35.14% |
| Average Basic Shares Outstanding | 4.10% | 3.61% | 3.13% | 2.69% | 2.34% |
| Average Diluted Shares Outstanding | 5.90% | 5.42% | 4.96% | 4.52% | 2.34% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |